Ilaria Del Giudice

Pubblicazioni

Titolo	Pubblicato in	Anno
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma	HEMATOLOGICAL ONCOLOGY	2020
COMPLEX KARYOTYPE IS ASSOCIATED WITH A LESS FAVORABLE OUTCOME AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114).	HemaSphere 2020; 4 (S1) p 290	2020
COMPLEX KARYOTYPE AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114)	Haematologica, 2020; 105(s2):s28	2020
Another step forward in the 20-year history of IGHV mutations in chronic lymphocytic leukemia	HAEMATOLOGICA	2019
Minimal residual disease monitoring in early stage follicular lymphoma can predict prognosis and drive treatment with rituximab after radiotherapy	BRITISH JOURNAL OF HAEMATOLOGY	2019
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia	BRITISH JOURNAL OF CANCER	2019
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?	FRONTIERS IN ONCOLOGY	2019
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network	HEMATOLOGICAL ONCOLOGY	2019
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IBRUTINIB TREATMENT.	HemaSphere	2019
IBRUTINIB TREATMENT DOESN’T INDUCE TP53 CLONAL EVOLUTION IN CHRONIC LYMPHOCYTIC LEUKEMIA.	Haematologica 2019; 104(s2):1	2019
Lymphomatoid granulomatosis and large granular lymphocyte leukemia, a rare association of two lymphoproliferative disorders	LEUKEMIA & LYMPHOMA	2018
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients	ANNALS OF ONCOLOGY	2018
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile	LEUKEMIA	2018
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease.	BRITISH JOURNAL OF HAEMATOLOGY	2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib	BRITISH JOURNAL OF HAEMATOLOGY	2018
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis	INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY	2018
TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IMMUNOCHEMOTHERAPY AND IBRUTINIB.	Haematologica, 2018; 103 (s3): s27	2018
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma	BRITISH JOURNAL OF HAEMATOLOGY	2017
Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients	ONCOTARGET	2017
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network.	LEUKEMIA & LYMPHOMA	2016

Pubblicazioni

Progetti di Ricerca